FDC
Back to Balance Sheet
|
FDC Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹108 Cr | ₹74 Cr | ₹60 Cr | ₹56 Cr | ₹38 Cr |
What is the latest Contingent Liabilities ratio of FDC ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹108 Cr |
| Mar2024 | ₹74 Cr |
| Mar2023 | ₹60 Cr |
| Mar2022 | ₹56 Cr |
| Mar2021 | ₹38 Cr |
How is Contingent Liabilities of FDC Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹108 Cr | 44.57 | |
| Mar2024 | ₹74 Cr | 24.95 | |
| Mar2023 | ₹60 Cr | 5.77 | |
| Mar2022 | ₹56 Cr | 48.30 | |
| Mar2021 | ₹38 Cr | - | |
Compare Contingent Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹6,560.8 Cr | -2.7% | -6.3% | -16.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -2.7% |
-6.3% |
-16.9% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses